Literature DB >> 10548481

p53-induced apoptosis as a safeguard against cancer.

C Asker1, K G Wiman, G Selivanova.   

Abstract

p53 acts as a potent tumor suppressor largely through its ability to induce cell death by apoptosis. Diverse cellular stress conditions, e.g., DNA damage, hypoxia, and oncogene activation, trigger p53-dependent apoptosis. ARF is a 14-kDa protein encoded by an alternative reading frame within the human INK4a locus that also encodes the p16 protein. ARF induces p53 in response to oncogene activation by preventing its degradation. This ensures the elimination of emerging tumor cells by p53-dependent apoptosis. p53 promotes apoptosis through multiple mechanisms, including transactivation of specific target genes, down-regulation of a distinct set of genes, and transcription-independent mechanisms. This may explain the frequent inactivation of ARF/p53 rather than downstream effectors during tumor development. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548481     DOI: 10.1006/bbrc.1999.1446

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.

Authors:  Laure Bidou; Olivier Bugaud; Valery Belakhov; Timor Baasov; Olivier Namy
Journal:  RNA Biol       Date:  2017-02-01       Impact factor: 4.652

3.  Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia.

Authors:  Jorge Cortes; Hagop Kantarjian; Edward D Ball; John Dipersio; Jonathan E Kolitz; Hugo F Fernandez; Mark Goodman; Gautam Borthakur; Maria R Baer; Meir Wetzler
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

4.  Adaptive methylation regulation of p53 pathway in sympatric speciation of blind mole rats, Spalax.

Authors:  Yang Zhao; Jia-Wei Tang; Zhi Yang; Yi-Bin Cao; Ji-Long Ren; Yuval Ben-Abu; Kexin Li; Xue-Qun Chen; Ji-Zeng Du; Eviatar Nevo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

5.  p53 Enables metabolic fitness and self-renewal of nephron progenitor cells.

Authors:  Yuwen Li; Jiao Liu; Wencheng Li; Aaron Brown; Melody Baddoo; Marilyn Li; Thomas Carroll; Leif Oxburgh; Yumei Feng; Zubaida Saifudeen
Journal:  Development       Date:  2015-04-01       Impact factor: 6.868

6.  T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation.

Authors:  Hui Feng; David L Stachura; Richard M White; Alejandro Gutierrez; Lu Zhang; Takaomi Sanda; Cicely A Jette; Joseph R Testa; Donna S Neuberg; David M Langenau; Jeffery L Kutok; Leonard I Zon; David Traver; Mark D Fleming; John P Kanki; A Thomas Look
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

Review 7.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

8.  Codon 104 variation of p53 gene provides adaptive apoptotic responses to extreme environments in mammals of the Tibet plateau.

Authors:  Yang Zhao; Ji-Long Ren; Ming-Yang Wang; Sheng-Ting Zhang; Yu Liu; Min Li; Yi-Bin Cao; Hu-Yue Zu; Xiao-Cheng Chen; Chung-I Wu; Eviatar Nevo; Xue-Qun Chen; Ji-Zeng Du
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 9.  Cellular adaptation to hypoxia and p53 transcription regulation.

Authors:  Yang Zhao; Xue-qun Chen; Ji-zeng Du
Journal:  J Zhejiang Univ Sci B       Date:  2009-05       Impact factor: 3.066

10.  Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer.

Authors:  Shin-ichi Yamashita; Masao Chujo; Michiyo Miyawaki; Keita Tokuishi; Kentaro Anami; Satoshi Yamamoto; Katsunobu Kawahara
Journal:  J Exp Clin Cancer Res       Date:  2009-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.